Abstract. Survivin is a bifunctional protein that suppresses apoptosis and regulates cell division, and is highly expressed in various cancer types. Mucins are high-molecular-weight, heavily glycosylated proteins. In the present study, the association between survivin, mucin 2 (MUC2) and MUC5 expression, and the clinicopathological features of colorectal cancer (CRC) were investigated. The immunohistochemistry and western blotting results demonstrated that survivin was highly expressed in CRC tissues and rarely expressed in normal colon tissues. Moreover, the overexpression of survivin and MUC5 was strongly associated with lymph node metastasis, poor cellular differentiation, advanced tumor stage and a poor prognosis in CRC. By contrast, low expression of MUC2 was significantly associated with lymph node metastasis, poor cellular differentiation and an advanced tumor stage in CRC. The results of the present study suggest that survivin, MUC2 and MUC5 levels may be associated with tumor progression and could be used to aid the early diagnosis and clinical characterization of CRC.
Introduction
Despite recent advances in detection and treatment, colorectal cancer (CRC) remains the third most common type of cancer and a major cause of cancer-related mortality worldwide (1, 2) .
There have been a number of recent advances in CRC screening. Probing a combination of sensitive and specific molecular markers could be particularly promising for early diagnosis, prediction of drug response and other clinical applications (3) . Survivin is a member of the inhibitor of apoptosis protein family. High survivin expression levels are associated with poor outcomes in the majority of cancer types (4) (5) (6) (7) (8) (9) . There is also evidence of survivin expression in specific adult tissues, including healthy oral epithelium, colonic epithelium, placenta and healthy endometrium (4, 10, 11) . A recent study reported that survivin can also act as a subunit of the chromosomal passenger complex (CPC), and direct the other subunits of CPC such as Aurora-B, Borealin and the inner centromere protein to regulate chromosome separation and cell division (4, 12) .
Mucins are high-molecular-weight, heavily glycosylated proteins (13) . At present, >20 mucin types have been identified and classified into two separate classes according to their structure and function (14) . The two structurally and functionally distinct classes are: i) Secreted gel-forming mucins (MUC2, MUC5AC, MUC5B and MUC6) and ii) transmembrane mucins (MUC1, MUC3A, MUC3B, MUC4, MUC12 and MUC17). The MUC2 glycoprotein is a secreted mucin that consists of two distinct regions with a high degree of internal homology (15) . MUC2 is commonly expressed in the healthy colonic epithelium and expression is decreased in non-mucinous colon adenocarcinomas (16) (17) (18) . MUC2 and MUC5AC are clustered at the same chromosomal locus (11p15.5), and their expression and function may be regulated by a common mechanism (19) . The MUC5AC gene is primarily expressed in the gastric and tracheobronchial mucosa; however, MUC5AC is not expressed in the healthy colonic epithelium (20) . Although the expression of MUC5AC increases in differentiated CRC, the absence of MUC5AC expression in tumors can be a prognostic factor for more aggressive colon adenocarcinomas (21) . Moreover, the expression of MUC2 and MUC5 is regulated by an extracellular signal-regulated kinase pathway in epithelial growth factor (EGF)/RAS proto-oncogene, GTPase (Ras)/Raf proto-oncogene, serine/threonine kinase (Raf)-positive cells (22) . A study have indicated that EGF-mutant cancer cell lines express high levels of survivin (23 Statistical analysis. The SPSS software package v.17.0 (SPSS, Inc., Chicago, IL, USA) was used for analysis. A χ 2 test was used for comparison of data between groups. Survival analyses were conducted using the Kaplan-Meier method and survival characteristics were compared using log-rank tests. P<0.05 was considered to indicate a statistically significant difference. (Table I and Fig. 1A) . Rates of high MUC5 expression (cytoplasmic staining) in the healthy colon mucosa and CRC tissue were 0% (0/20) and 28.06% (39/139), respectively (Table I and Fig. 1A ). In conclusion, the expression and staining intensity of survivin and MUC5 were significantly increased in CRC tissues (P<0.01), whereas those of MUC2 were significantly decreased in CRC tissues (P<0.01).
Results

Expression of survivin, MUC2 and MUC5 in healthy and
Western blot analysis revealed that the expression levels of survivin and MUC5 in healthy colon mucosa tissues were lower than levels in CRC tissues (Fig. 1B) . However, expression levels of MUC2 in the healthy colon mucosa were higher than levels in CRC tissues (Fig. 1B) . These findings support the immunohistochemical data, as high expression of MUC2 was observed in healthy colon mucosa, whereas high expression of survivin and MUC5 was observed in CRC cells (Fig. 1B) .
Survivin expression and correlation with MUC2, MUC5, Ki-67 and clinicopathological features in CRC.
The present study examined the correlation between survivin, MUC2, MUC5 and Ki-67 in CRC cases. A total of 55/139 patients with CRC exhibited high survivin expression levels (Table II) This demonstrated that survivin expression was directly associated with MUC5 and Ki-67 expression, and inversely correlated with MUC2 expression in CRC (P<0.01).
Patients with high survivin expression levels demonstrated significantly increased incidences of lymph node metastasis (P<0.01) and stage-D tumors (P<0.01) (8 Edition, Japanese Classification of Colorectal Carcinoma) (10,11) compared with cases exhibiting low survivin expression levels (Table III) . However, no evidence of association between survivin expression level and tumor size, gender or histological differentiation was found.
Patients with low MUC2 expression levels demonstrated significantly lower cell differentiation (P<0.01) and higher incidences of lymph node metastasis (P<0.05) and stage-D tumors (P<0.01) when compared with cases displaying high expression of MUC2 (Table IV) . The association between clinicopathological factors and MUC5 expression in CRC was also examined. In comparison to MUC2, patients expressing high levels of MUC5 tended to exhibit poor CRC cell differentiation (P<0.05), higher rates of lymph node metastasis (P<0.01) and higher tumor stage (P<0.01) (Table IV) .
Survival analysis. The Kaplan-Meier method was used to assess the survival rate of 139 patients who expressed survivin, MUC2 and MUC5 (Fig. 2) . The 5-year survival rate of those whose tumors expressed low levels of survivin and MUC5 was higher than that of patients with high expression levels of survivin and MUC5. By comparison, the 5-year survival rate of those with tumors expressing high levels of MUC2 was higher than that of patients whose tumors expressed low levels of MUC2.
Discussion
Survivin is a bifunctional protein that suppresses apoptosis and regulates cell division, which is highly expressed in various cancer types (12) . Additionally, >20 mucins are classified as either secreted mucins or transmembrane mucins according to their structure and function (13) . MUC2 and MUC5 are secreted mucins. However, to the best of our knowledge, there have been no studies to date investigating the correlation of survivin expression with MUC2 and MUC5 expression in CRC. The present study focused on the expression levels of survivin, MUC2 and MUC5 in healthy and CRC tissues using immunohistochemical analysis. Additionally, the present study aimed to investigate the potential of these biomarkers to aid in the early diagnosis of CRCs, as well as other clinical applications. In this study, survivin was revealed to be expressed at high levels in CRC tissues, but at low levels in healthy colon tissues ( Fig. 1 and Table I ). Moreover, patients with high expression of survivin demonstrated significantly poorer cellular differentiation, higher rates of lymph node metastasis and a higher incidence of stage-D tumors than did cases with low expression of survivin. Furthermore, overexpression of survivin has previously been found to be associated with poor prognosis in CRC, HCC, and head and neck cancer (4, (10) (11) (12) .
n -----------------------------------------------------------------------------------------
The present study also examined the expression levels of MUC2 and MUC5 in healthy colon mucosa and in CRC patients. MUC2 was found to be expressed at high levels in normal colon tissue and at lower levels in CRC tissue ( Fig. 1 and Table I ). Moreover, cases with low expression of MUC2 demonstrated significantly poorer cell differentiation, higher rates of lymph node metastasis and a higher incidence of stage-D tumors compared with cases with high levels of expressed MUC2. Similarly, several studies have shown that loss of MUC2 expression is correlated with poor prognosis in CRC (24) (25) (26) . Notably, however, another study found that overexpression of MUC2 is associated with poorer overall survival (27) . In a further previous study, decreased expression of MUC2 was found to be associated with colon carcinogenesis, decreased apoptosis and increased migration of intestinal epithelial cells (20) .
A number of studies have shown that low expression of MUC2 is associated with poorly differentiated adenocarcinoma of the colon and rectum (28, 29) . By contrast, in the present study, MUC5 was expressed at high levels in CRC tissues but at low levels in normal colon tissues ( Fig. 1 and Table I ). Similarly, other studies have shown that MUC5AC is not detected in the normal colon, but is frequently found in adenomas and carcinomas (18, (30) (31) (32) . Other prior studies reported that an increase in expression of MUC5AC was observed in sporadic cancer with high microsatellite instability (33) and that MUC5AC expression in intrahepatic cholangiocarcinoma was found to be an independent prognostic factor by multivariate survival analysis (34) . The presence of MUC2 and/or MUC5AC in colorectal mucinous adenocarcinoma has been shown to be associated with proximal (right-sided) CRC location (32, 33) . There was no statistically significant association between gender and expression of MUC2 and/or MUC5 in the present study. Expression of survivin was also compared with the expression of MUC2, MUC5 and Ki-67 ( Fig. 1 ; Table II) . Survivin expression was found to be directly correlated with MUC5 and Ki-67 expression, and inversely correlated with MUC2 expression (Fig. 1 and Table II ). These findings led to the hypothesis that survivin and MUC5 are expressed at high levels in CRC, whereas low MUC2 expression levels confer a poor prognosis in CRC.
In conclusion, the present study revealed that the normal-to-carcinoma sequence was significantly associated with the high expression and staining intensity of survivin and MUC5 (P<0.01), and the low expression of MUC2. Additionally, cases with high expression of survivin and MUC5 and/or low expression of MUC2 demonstrated significantly increased rates of lymph node metastasis and incidences of advanced tumor stage. Therefore, increased survivin and MUC5 or decreased MUC2 expression levels are associated with the malignant potential of colon carcinoma. Further investigations Table III . Survivin expression and its correlation with clinicopathological findings in colorectal cancer. using appropriate techniques based on clinical data are required to confirm the present findings.
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